Nuzenio

Foghorn Therapeutics Reports

Foghorn Therapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Axsome Therapeutics Inc (AXSM) News, Articles, Events & Latest Updates - StocktwitsStocktwits · Fri, 07 Aug 2026 18:38:37 GMT Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 14:22:59 GMT Foghorn Therapeutics (NASDAQ:FHTX) Issues Earnings Results, Beats Estimates By $0.13 EPS - MarketBeatMarketBeat · Fri, 07 Aug 2026 03:34:50 GMT Foghorn Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 14:20:38 GMT Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:06 GMT Foghorn Therapeutics Inc. 2026: Revenue $16.07M, EPS ($0.1) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMT Lilly deal lifts Foghorn Therapeutics (Nasdaq: FHTX) Q2 2026 revenue and cuts loss - Stock TitanStock Titan · Thu, 06 Aug 2026 11:03:33 GMT Foghorn’s lung cancer trial advances; IND targeted for 2027 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:38:37 GMTAxsome Therapeutics Inc (AXSM) News, Articles, Events & Latest Updates - Stocktwits

Fri, 07 Aug 2026 14:22:59 GMTAxsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo! Finance Canada

Fri, 07 Aug 2026 03:34:50 GMTFoghorn Therapeutics (NASDAQ:FHTX) Issues Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat

Thu, 06 Aug 2026 14:20:38 GMTFoghorn Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView

Thu, 06 Aug 2026 13:50:06 GMTFoghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Thu, 06 Aug 2026 11:11:00 GMTFoghorn Therapeutics Inc. 2026: Revenue $16.07M, EPS ($0.1) — 10-Q Summary - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

FHTX8 live mentions Inc5 live mentions AXSM4 live mentions Foghorn Therapeutics4 live mentions EPS3 live mentions Foghorn Therapeutics Inc3 live mentions Articles2 live mentions Events2 live mentions Stock Price2 live mentions Quote2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Foghorn Therapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.